Le Lézard
Classified in: Health, Business
Subject: DIV

Medical Facilities Corporation Announces September Dividend


/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED STATES/

TORONTO, Sept. 19, 2018 /CNW/ - Medical Facilities Corporation (TSX: DR) ("Medical Facilities" or the "Company") announced today that a cash dividend payment of Cdn$0.09375 per common share will be payable on October 15, 2018 to holders of record of common shares at the close of business on September 28, 2018. This will be the Company's 174th consecutive dividend payment since inception.

The ex-dividend date for this distribution will be September 27, 2018. Medical Facilities designates this dividend to be an "eligible dividend" pursuant to subsection 89(14) of the Income Tax Act (Canada) and its equivalent in any provinces of Canada.

About Medical Facilities Corporation
Medical Facilities, in partnership with physicians, owns surgical facilities in the United States. Medical Facilities' portfolio includes controlling interest in five specialty surgical hospitals located in Arkansas, Indiana, Oklahoma, and South Dakota, and an ambulatory surgery center located in California. In addition, through a partnership with NueHealth LLC, Medical Facilities owns controlling interest in seven ambulatory surgery centers located in Arkansas, Michigan, Missouri, Nebraska, Ohio, Oregon, and Pennsylvania. The specialty surgical hospitals perform scheduled surgical, imaging, diagnostic and other procedures, including primary and urgent care, and derive their revenue from the fees charged for the use of their facilities. The ambulatory surgery centers specialize in outpatient surgical procedures, with patient stays of less than 24 hours. Medical Facilities is structured so that a majority of its free cash flow from operations is distributed to the holders of its common shares in the form of dividends. For more information, please visit www.medicalfacilitiescorp.ca.

Caution concerning forward-looking statements
Statements made in this news release, other than those concerning historical financial information, may be forward-looking and therefore subject to various risks and uncertainties.  Some forward-looking statements may be identified by words like "may", "will", "anticipate", "estimate", "expect", "intend", or "continue" or the negative thereof or similar variations.  Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements.  Factors that could cause results to vary include those identified in Medical Facilities' filings with Canadian securities regulatory authorities such as legislative or regulatory developments, intensifying competition, technological change and general economic conditions.  All forward-looking statements presented herein should be considered in conjunction with such filings.  Medical Facilities does not undertake to update any forward-looking statements; such statements speak only as of the date made.

SOURCE Medical Facilities Corporation


These press releases may also interest you

at 15:30
The Magic Mushroom Delivery, a prominent leader in the magic mushroom industry, has seen significant growth in recent year, expanding its services to offer both same-day delivery in California and fast nationwide shipping. Based in Oakland,...

at 15:30
In response to President Biden's Executive Order 14081, "Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy," the U.S. Environmental Protection Agency (EPA), the U.S. Food and Drug...

at 15:30
Thought Technology Ltd., a well-established name in the biofeedback equipment sector, is delighted to announce its 50th anniversary. Since its inception, the company has been at the...

at 15:28
Retired New Jersey Marine Robert Hanley became the 7,000th patient to complete treatment at ProCure Proton Therapy Center, surpassing a major milestone at the tri-state region's original proton therapy facility. Hanley was diagnosed with lung cancer...

at 15:20
ArkeaBiotm, a leading ag-biotech start-up developing a vaccine to reduce livestock methane emissions, today announced the close of a $26.5 million Series A financing round. The raise was led by current investor Breakthrough Energy Ventures (BEV), and...

at 14:55
According to Arizton's latest focus insight report, the US laboratory developed tests market is growing at a CAGR of 3.40% from 2023 to 2029....



News published on and distributed by: